Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
One shot of REGEN-COV prevents COVID infection for 8 months, clinical trial finds
Nov 09, 2021
A single dose delivered by subcutaneous injection cut the 8-month risk of contracting COVID-19 by 82% — nearly the same rate of protection found at one month, the company announced Monday.
LTC docs urge peers to rapidly increase use of COVID-19 antibody drugs
Nov 03, 2021
Industry geriatricians have compiled resources for their LTC peers who have not yet come on board with monoclonal antibody treatments. Resident immunity to COVID-19 is declining, and mAbs may prevent hospital...
Long-term care left behind in race to nab COVID monoclonal antibodies: report
Nov 02, 2021
Delayed shipments of antibody doses are putting residents’ lives at risk after federal authorities barred direct orders of the drugs, LTC clinicians say.
A first? COVID antibody therapy with full-year protection is up for FDA authorization
Oct 08, 2021
Drugmaker AstraZeneca has asked the FDA to authorize what it says could be the first long-acting monoclonal antibody drug therapy for the prevention of COVID-19 in at-risk patients.
Clinical briefs for Friday, Oct 1
Oct 01, 2021
REGEN-COV antibody treatment cuts severe COVID risk at half dose, late-stage trial results show … Drug improves memory and function for those with dementia and ‘silent seizures’ … Depression relapse...
WHO issues guidance for use of casirivimab-imdevimab in COVID-19
Sep 24, 2021
Combo conditionally recommended for patients with nonsevere disease at risk for severe disease, seronegative patients with severe infection
WHO: Antibody treatment most beneficial for seniors, the unvaccinated, and immunocompromised
Sep 27, 2021
The World Health Organization’s new guidance for using the REGEN-COV monoclonal antibody cocktail to treat COVID-19 covers a narrower group of patients than those included in the FDA’s updated...
Government buys more monoclonal antibody treatments to ward off shortage
Sep 16, 2021
Biden administration has also taken over distributing the therapeutics to help avoid shortages and to ensure equitable distribution
Clinical briefs for Thursday, Sept. 16
Sep 16, 2021
U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...